Semin Reprod Med 2016; 34(02): 110-120
DOI: 10.1055/s-0035-1571196
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Type 1 and Type 2 Diabetes Preconception and in Pregnancy: Health Impacts, Influence of Obesity and Lifestyle, and Principles of Management

Sally K. Abell
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventative Medicine, Monash University, Clayton, Victoria, Australia
2   Diabetes and Vascular Medicine Unit, Monash Health, Victoria, Australia
,
Alison Nankervis
3   Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia
4   Diabetes Service, Royal Women's Hospital, Parkville, Victoria, Australia
5   Department of Medicine, University of Melbourne, Victoria, Australia
,
Khalid S. Khan
6   Department of Women's Health and Clinical Epidemiology, Blizard Institute, Barts and the London School of Medicine, London, United Kingdom
,
Helena J. Teede
1   Monash Centre for Health Research and Implementation, School of Public Health and Preventative Medicine, Monash University, Clayton, Victoria, Australia
2   Diabetes and Vascular Medicine Unit, Monash Health, Victoria, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
08 February 2016 (online)

Abstract

Preexisting diabetes in pregnancy results in increased risks to the mother, fetus, and neonate. Preconception care is vital to reduce risk of miscarriage, congenital malformations, and perinatal mortality. Preconception care should empower women with realistic goal setting, healthy lifestyle, and diabetes self-management skills, to ensure a positive experience of the pregnancy and to reduce diabetes-related distress. In high-risk women without known diabetes, preconception and early antenatal screening is crucial to enable prompt treatment of hyperglycemia and any complications. The prevalence of obesity in reproductive age women is rising, further increasing risk of poor pregnancy outcomes in women with diabetes. Adverse lifestyle factors should be addressed preconception and in the antenatal period, allowing opportunity to improve physical health, manage weight, and improve neonatal outcomes. Management of diabetes in pregnancy involves individualized and intensified insulin therapy, accounting for expected changes in insulin sensitivity, and minimizing glucose variability and hypoglycemia. Diabetes complications must be screened for and managed as necessary. Delivery timing will depend on fetal surveillance and obstetric considerations. It is important to maintain engagement and motivation of these women in the postpartum period, encouraging breastfeeding and postpartum weight management and supporting diabetes management.

Contribution to Authorship

S. K. A., A. N., and H. J. T. planned the study outline and wrote the manuscript. S. K. A., A. N., K. S. K., and H. J. T. all critically reviewed the final manuscript and provided significant intellectual contribution.


 
  • References

  • 1 Jovanovič L, Liang Y, Weng W, Hamilton M, Chen L, Wintfeld N. Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy. Diabetes Metab Res Rev 2015; 31 (7) 707-716
  • 2 Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103 (2) 176-185
  • 3 McIntyre HD, Thomae MK, Wong SF, Idris N, Callaway LK. Pregnancy in type 2 diabetes mellitus—problems & promises. Curr Diabetes Rev 2009; 5 (3) 190-200
  • 4 Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010; 39 (3) 481-497
  • 5 Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990; 7 (4) 360
  • 6 Lapolla A, Dalfrà MG, Di Cianni G, Bonomo M, Parretti E, Mello G ; Scientific Committee of the GISOGD Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis 2008; 18 (4) 291-297
  • 7 Boulot P, Chabbert-Buffet N, d'Ercole C , et al; Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26 (11) 2990-2993
  • 8 Potti S, Sliwinski CS, Jain NJ, Dandolu V. Obstetric outcomes in normal weight and obese women in relation to gestational weight gain: comparison between Institute of Medicine guidelines and Cedergren criteria. Am J Perinatol 2010; 27 (5) 415-420
  • 9 Fraser A, Lawlor DA. Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr Diab Rep 2014; 14 (5) 489
  • 10 Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB ; Diabetes Endocrine Pregnancy Outcome Study in Toronto. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. QJM 2001; 94 (7) 347-356
  • 11 Persson M, Pasupathy D, Hanson U, Westgren M, Norman M. Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study. BMJ Open 2012; 2 (1) e000601
  • 12 Singh H, Murphy HR, Hendrieckx C, Ritterband L, Speight J. The challenges and future considerations regarding pregnancy-related outcomes in women with pre-existing diabetes. Curr Diab Rep 2013; 13 (6) 869-876
  • 13 Mathiesen ER, Ringholm L, Damm P. Therapeutic management of type 1 diabetes before and during pregnancy. Expert Opin Pharmacother 2011; 12 (5) 779-786
  • 14 Cundy T, Morgan J, O'Beirne C , et al. Obstetric interventions for women with type 1 or type 2 diabetes. Int J Gynaecol Obstet 2013; 123 (1) 50-53
  • 15 Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 2009; 32 (11) 2005-2009
  • 16 Ringholm L, Mathiesen ER, Kelstrup L, Damm P. Managing type 1 diabetes mellitus in pregnancy—from planning to breastfeeding. Nat Rev Endocrinol 2012; 8 (11) 659-667
  • 17 Barbour LA. Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short- and long-term outcomes. Curr Opin Endocrinol Diabetes Obes 2014; 21 (4) 257-263
  • 18 Dabelea D, Mayer-Davis EJ, Lamichhane AP , et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 2008; 31 (7) 1422-1426
  • 19 Shannon GD, Alberg C, Nacul L, Pashayan N. Preconception healthcare delivery at a population level: construction of public health models of preconception care. Matern Child Health J 2014; 18 (6) 1512-1531
  • 20 Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6 (3) 219-223
  • 21 Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 1979; 28 (4) 292-293
  • 22 Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies?. BMJ 1990; 301 (6760) 1070-1074
  • 23 Janz NK, Herman WH, Becker MP , et al. Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes Care 1995; 18 (2) 157-165
  • 24 Komiti A, Jackson HJ, Nankervis A, Conn J, Allan C, Judd F. An investigation of psycho-social factors associated with the uptake of pre-pregnancy care in Australian women with type 1 and type 2 diabetes. J Psychosom Obstet Gynaecol 2013; 34 (2) 75-81
  • 25 Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2010; 10: 63
  • 26 Wald NJ. Folic acid and the prevention of neural-tube defects. N Engl J Med 2004; 350 (2) 101-103
  • 27 Bick D, Beake S, Chappell L , et al. Management of pregnant and postnatal women with pre-existing diabetes or cardiac disease using multi-disciplinary team models of care: a systematic review. BMC Pregnancy Childbirth 2014; 14: 428
  • 28 National Institute for Health and Care Excellence. Diabetes in pregnancy management of diabetes and its complications from preconception to the postnatal period. NICE guidelines. Published: February 25, 2015. Available at: http://nice.org.uk/guidance/ng3 . Accessed November 2, 2015
  • 29 Tieu J, Middleton P, Crowther CA. Preconception care for diabetic women for improving maternal and infant health. Cochrane Database Syst Rev 2010; (12) CD007776
  • 30 Owens LA, Avalos G, Kirwan B, Carmody L, Dunne F. ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care 2012; 35 (8) 1669-1671
  • 31 Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001; 94 (8) 435-444
  • 32 Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006; 29 (8) 1744-1749
  • 33 Murphy HR, Roland JM, Skinner TC , et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 2010; 33 (12) 2514-2520
  • 34 Lapolla A, Dalfrà MG, Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract 2008; 80 (1) 2-7
  • 35 Balsells M, García-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009; 94 (11) 4284-4291
  • 36 Glinianaia SV, Tennant PW, Crowder D, Nayar R, Bell R. Fifteen-year trends and predictors of preparation for pregnancy in women with pre-conception Type 1 and Type 2 diabetes: a population-based cohort study. Diabet Med 2014; 31 (9) 1104-1113
  • 37 Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 2006; 6: 30
  • 38 Nielsen GL, Møller M, Sørensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care 2006; 29 (12) 2612-2616
  • 39 Glinianaia SV, Tennant PW, Bilous RW, Rankin J, Bell R. HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia 2012; 55 (12) 3193-3203
  • 40 McIntyre HD, Flack JR ; National Diabetes in Pregnancy Advisory Committee. Consensus statement on diabetes control in preparation for pregnancy. Med J Aust 2004; 181 (6) 326
  • 41 Kallas-Koeman MM, Kong JM, Klinke JA , et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia 2014; 57 (4) 681-689
  • 42 Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care 2013; 36 (7) 1877-1883
  • 43 Ranasinghe PD, Maruthur NM, Nicholson WK , et al. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 2015; 24 (3) 237-249
  • 44 Mello G, Biagioni S, Ottanelli S , et al. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women. J Matern Fetal Neonatal Med 2015; 28 (3) 276-280
  • 45 Murphy HR, Kumareswaran K, Elleri D , et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care 2011; 34 (12) 2527-2529
  • 46 Hughes RC, Rowan JA. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?. Diabet Med 2006; 23 (3) 318-322
  • 47 American Diabetes Association. Standards of medical care in diabetes - 2015. Diabetes Care 2015; 38 (Suppl. 01) 11-66
  • 48 ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 2005; 105 (3) 675-685
  • 49 Thompson D, Berger H, Feig D , et al; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Diabetes and pregnancy. Can J Diabetes 2013; 37 (Suppl. 01) S168-S183
  • 50 Blumer I, Hadar E, Hadden DR , et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98 (11) 4227-4249
  • 51 McElduff A, Cheung NW, McIntyre HD , et al; Australasian Diabetes in Pregnancy Society. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183 (7) 373-377
  • 52 IDF Clinical Guidelines Task Force. Global Guideline on Pregnancy and Diabetes. Brussels: International Diabetes Federation. Available at: www.idf.org ; Accessed November 2, 2015
  • 53 Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000; 23 (8) 1084-1091
  • 54 Vérier-Mine O, Chaturvedi N, Webb D, Fuller JH. Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study. Diabet Med 2005; 22 (11) 1503-1509
  • 55 Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 2001; 18 (7) 573-577
  • 56 Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008; 51 (6) 1041-1045
  • 57 Piccoli GB, Clari R, Ghiotto S , et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud 2013; 10 (1) 6-26
  • 58 Scialli AR, Lione A. ACE inhibitors and major congenital malformations. N Engl J Med 2006; 355 (12) 1280 , author reply 1281
  • 59 Barrett HL, Dekker Nitert M, McIntyre HD, Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids?. Diabetes Care 2014; 37 (5) 1484-1493
  • 60 Institute of Medicine. Weight Gain during Pregnancy: Reexamining the Guidelines. In: Rasmussen KM, Yaktine AL. , eds. Washington, DC: National Academies Press (US), National Academy of Sciences; 2009
  • 61 Teede HHC, Lombard C, Boyle J, East C, Brown W. Case for action proposal: obesity prevention through preventing excess weight gain during pregnancy and postpartum. Submitted by the NHMRC Research Translation Faculty Obesity Steering Group; September 2014. Available at: www.nhmrc.gov.au/research/research-translation/research-translation-faculty/ideas-research-translation-faculty-cases . Accessed January 19, 2016
  • 62 Catalano P, deMouzon SH. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int J Obes 2015; 39 (4) 642-649
  • 63 Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311 (8) 806-814
  • 64 Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, Maria Siega-Riz A. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 2010; 116 (5) 1191-1195
  • 65 Secher AL, Parellada CB, Ringholm L, Asbjörnsdóttir B, Damm P, Mathiesen ER. Higher gestational weight gain is associated with increasing offspring birth weight independent of maternal glycemic control in women with type 1 diabetes. Diabetes Care 2014; 37 (10) 2677-2684
  • 66 Harrison CL, Lombard CB, Teede HJ. Limiting postpartum weight retention through early antenatal intervention: the HeLP-her randomised controlled trial. Int J Behav Nutr Phys Act 2014; 11: 134
  • 67 Harrison CL, Lombard CB, Strauss BJ, Teede HJ. Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity (Silver Spring) 2013; 21 (5) 904-909
  • 68 Dodd JM, McPhee AJ, Turnbull D , et al; LIMIT Randomised Trial Group. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Med 2014; 12: 163-171
  • 69 Poston L, Bell R, Croker H , et al; UPBEAT Trial Consortium. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 2015; 3 (10) 767-777
  • 70 Thangaratinam S, Rogozinska E, Jolly K , et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012; 344: e2088
  • 71 Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev 2015; 6: CD007145
  • 72 Thangaratinam S. Diet and lifestyle interventions for obese pregnant women. Lancet Diabetes Endocrinol 2015; 3 (10) 748-749
  • 73 Barbour LA. Weight gain in pregnancy: is less truly more for mother and infant?. Obstet Med 2012; 5 (2) 58-64
  • 74 Asbjörnsdóttir B, Rasmussen SS, Kelstrup L, Damm P, Mathiesen ER. Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes. Diabetes Care 2013; 36 (5) 1102-1106
  • 75 Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol 2003; 109 (1) 41-44
  • 76 Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010; 115 (3) 597-604
  • 77 Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care 2014; 37 (11) 2953-2959
  • 78 Petrović O. How should we screen for gestational diabetes?. Curr Opin Obstet Gynecol 2014; 26 (2) 54-60
  • 79 García-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 2010; 53 (3) 446-451
  • 80 de Veciana M. Diabetes ketoacidosis in pregnancy. Semin Perinatol 2013; 37 (4) 267-273
  • 81 Hewapathirana NM, Murphy HR. Perinatal outcomes in type 2 diabetes. Curr Diab Rep 2014; 14 (2) 461
  • 82 Illsley NP. Placental glucose transport in diabetic pregnancy. Clin Obstet Gynecol 2000; 43 (1) 116-126
  • 83 Cundy T, Gamble G, Neale L , et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care 2007; 30 (10) 2603-2607
  • 84 Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N ; Northern Diabetic Pregnancy Survey Steering Group. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008; 115 (4) 445-452
  • 85 Achong N, Duncan EL, McIntyre HD, Callaway L. Peripartum management of glycemia in women with type 1 diabetes. Diabetes Care 2014; 37 (2) 364-371
  • 86 Gilmore LA, Klempel-Donchenko M, Redman LM. Pregnancy as a window to future health: Excessive gestational weight gain and obesity. Semin Perinatol 2015; 39 (4) 296-303
  • 87 World Health Organization. Infants and Young Children Feeding: Model Chapter for Textbooks for Medical Students and Allied Health Professionals. WHO Press; 2009
  • 88 Ip S, Chung M, Raman G , et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 2007; (153) 1-186
  • 89 Finkelstein SA, Keely E, Feig DS, Tu X, Yasseen III AS, Walker M. Breastfeeding in women with diabetes: lower rates despite greater rewards. A population-based study. Diabet Med 2013; 30 (9) 1094-1101
  • 90 Herskin CW, Stage E, Barfred C , et al. Low prevalence of long-term breastfeeding among women with type 2 diabetes. J Matern Fetal Neonatal Med 2015; DOI:10.3109/14767058.2015.1092138 1-6
  • 91 Turcksin R, Bel S, Galjaard S, Devlieger R. Maternal obesity and breastfeeding intention, initiation, intensity and duration: a systematic review. Matern Child Nutr 2014; 10 (2) 166-183